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Preliminary Results of two components:  
KIIs and the Pharmacy Study 
 
Population Council: 
Wilson Liambila, Harriet Birungi; Francis Onyango and  
Brian Mdawida. 
 
Marie Stopes   
Vitalis Akora, Thoai Ngo and Kate Reiss  
AVAILABILITY, USE AND QUALITY OF 
CARE FOR MEDICAL ABORTION SERVICES 
BACKGROUND 
• Presentation – part of activities being implemented 
under The STEP UP (Strengthening Evidence for 
Programming on Unintended Pregnancy) 
Research Programme Consortium, which generates 
policy-relevant research to promote an evidence-
based approach for improving access to FP and safe 
abortion. 
• STEP UP focuses its activities in five countries: 
Bangladesh, Ghana, India, Kenya, and Senegal.  
• STEP UP is coordinated by PC in partnership with 
APHRC; ICDDR,B; the LSH&TM ; MSI/MSK and 
Partners in Population and Development (PPD). 
Funded by UK-aid 
Opportunities/Problem Statement 
 Renewed interest in MM and unsafe abortion since 
2010 (New Const. Expansion of MA services), MDG5  
 The incidence and complications of unsafe abortion 
report-shows high incid.464,690 induced abortions 
in Kenya in 2012 (rate: 48/1000 women- 15-49 yrs  
 In Kenya, little is known about: 
 The private sector provision of MAS, 
 Acceptability of MAS among Pharmacy staff and 
clients, and the content of care offered  
 QOC for MA services in the Private Sector clinics  
 Provision of FP services in the Private Sector HFs 
Opportunities – Many resources now 
available to support safe abortion services 
Output 1: A coherent body of robust research 
based evidence generated to address STEP UP’s 
priority areas. 
Developing a conceptual framework for UP  
Building the evidence base for understanding UP in 
Kenya – Country Profile (APHRC, PC, PPD) 
Addressing UP among adolescents girls living in 
urban slums of Kenya (APHRC, MSK) 
Assessing the use, availability and quality 
of care for medical abortion services in 
Kenya (PC, MSK, RHN) 
 
STEP-UP in Kenya – what are we doing? 
a) Determine the activities being undertaken to 
support the expansion of MA services, 
b) Determine the preparedness of private 
facilities to provide MA services to clients 
c) Assess the availability and provision practices 
of misoprostol & mifepristone in private 
outlets; and 
d) Explore the information given to clients 
seeking MAS at private clinics and pharmacies 
 Objectives of the project  
STUDY DESIGN & METHODOLOGY  
 Cross-sectional exploratory study 
 Three components 
KIIs (Policy Makers and prog.mgrs -NBO, KSM)  
Pharmacy study 
Clinic-based study  (Not covered in this presentation) 
 Study sites (Kisumu, Nairobi and Mombasa) 
 Data collection 
 Individual interviews held with Snr mgrs (19)  
Structured interviews with pharmacy/ass.(235) 
MCs (100pharmacies-i.e.appr.33/site= 400visits)   
 
………Key Issues Explored 
Key Informant Interviews: 
New Const; opportunities, challenges, interventions, 
M/E; QOC, Capacity building, public HFs & Advocacy 
Pharmacy assistant interviews: 
Background characteristics, Training and knowledge, 
service provision, FP services, cost of drugs for MA 
Simulated clients: 
Assume specific roles of real clients seeking MA 
services, ask for services in the assumed role, 
observe the provider’s ability to respond to the needs 
of SCs & complete a short tool immediately after visit  
FINDINGS 
1) Key Informant Interviews - KIIs 
• The 2010 new const. has provided a new 
supportive legal framework   
• S/Abortion services are now more available   
• Peoples’ perceptions regarding abortion changing. 
• However, negative attitudes and beliefs still 
persist among HWs, police; judiciary the public. 
• There is still some apprehension to provide MA  
services in the public sector facilities.  
 
 
2) Pharmacy Assistant interviews: 
 
Age Distribution of Pharmacy Assistants   
Age N=235      
n % 
22-30 yrs 140 59.6 
31-40 yrs 81 34.4 
> 41yrs  14 6.0 
Total 100.0 
Education Levels of PAs 
 Education 
Level 
N=235 
n             % 
Primary 5 (2.1) 
Secondary 11 (4.7) 
College 191 (81.3) 
University 28 (11.9) 
235 (100.0) 
Trained in TOP services 
Position N=235 
n % 
owner 3 (1.3) 
Manager 1 (0.4) 
Employee 28 (11.9) 
32 (13.6) 
Only a few clients who purchased Miso/Mife  
were provided with an FP Method 
Does the Pharmacy Sell? 
(YES) 
N=215 
Pur. Miso, 
Mife & FP  
n  % n=5 
Male Condom 200 93. 1 
Female Condom 53 25 1 
Pills 213 99 1 
Diaphgram 16 7 0 
Foam Pills 22 10 0 
Injectables(3 Months) 163 76 1 
Injectables (2 Months) 24 11 0 
Implants/Jadelle 36 17 1 
EC 201 94 0 
Miso/Mife or Comb (N=234)  26 (11) 
3) Results of Mystery Client Experiences 
With Pharmacy Assistants 
 
Number of Visits made by MC by scenario 
 
Client Scenario  
N=401 
n  % 
Wants misoprostol 101 25.2 
Pregnant & seeking help to end it 100 24.9 
Seeking medication to end 2 
months pregnancy 101 
25.2 
Seeking medication to end 12 
weeks (3months) pregnancy 99 24.7 
Total 401 100.0 
Number of staff MCs interacted with 
 
Client Scenario 
No. of staff MCs interacted with 
1 % 2 % 
3 or 
more 
% 
309  82 61  16 7  2 
Wants misoprostol 
87 86 12 12 1 1 
Pregnant and seeking 
help to end it 
65 65 19 19 1 1 
Seeking medication to 
end 2 months pregnancy 
78 77 12 12 4 4 
Seeking medication to 
end 3 months pregnancy 
79 80 18 18 1 1 
History Taking and Screening 
Client Scenario 1 2 3 4 
Staff asked about: 101  % 100  % 101  % 99  % 
LMP 7 7 39 39 33 33 74 75 
Gestation age  29 29 50 50 76 75 64 65 
Medical History 0 0 6 6 2 2 18 18 
Age 6 6 26 26 24 24 38 38 
SES 4 4 40 40 31 31 37 37 
Reasons for 
termination 
14 14 57 57 49 49 65 66 
Prescription from 
m/practitioner 
45 45 24 24 14 14 33 33 
Proof of permission 
from 3rd Parties 
0 0 3 3 13 13 28 28 
Service Provision By Scenario 
Client Scenario 1 2 3 4 
Staff Advised on: 
n= 
101 
 % 
n= 
100 
 % 
n= 
101 
 % 
n= 
99 
 % 
Continuing with 
Pregnancy 
10 10 45 45 25 25 59 60 
Seeking counseling 
before TOP  
17 17 12 12 7 7 28 28 
Where to obtain 
services TOP  
17 17 12 12 7 7 28 28 
Available TOP 
methods 
28 28 50 50 54 53 69 70 
Service Provision: Does Knowing ones 
SES influence Method type?  
For MA medications offered, pharmacy 
staff explained… 
 Client Scenario 1 2 3 4 
101  % 100  % 101  % 99  % 
When to use  med 
5 5 6 6 19 19 12 12 
How to take med 5 5 19 19 22 22 14 14 
How med. works 6 6 20 20 23 23 16 16 
Side-effects of med 22 22 18 18 11 11 10 10 
Effectiveness  9 9 13 13 11 11 16 16 
When to seek help 3 3 3 3 9 9 8 8 
Complications 12 12 17 17 13 13 9 9 
Where to seek help 3 3 6 6 6 6 11 11 
Staff rarely discussed  FP with their clients  
 Did the pharmacy staff?  N=401 
n  % 
Discuss Family Planning 48 12 
Recommend Family Planning 37 8.7 
Provide FP method 2 0.5 
Refer client elsewhere for FP 
method 4 1 
FP rarely discussed across Scenarios 
Did the 
Pharmacy 
Staff…… 
Discuss  
FP? 
Recom 
mend FP? 
Give FP 
method? 
Refer 
client for 
FP? 
Client 
Scenario n 
=101 
 % 
n 
=100 
 % 
n 
=101 
 % 
n  
=99 
 % 
Wants 
misoprostol 
6 6 5 5 0 0 0 0 
Preg. & seeking 
help to end it 
7 7 7 7 1 1 1 1 
Seeking med.to 
end 2/12 preg. 
19 19 11 11 0 0 0 0 
Seeking med. 
to end 3/12 
pregnancy  
16 16 12 12 1 1 3 3 
 4. Experiences 
Observed by RAs 
(during Data 
Collection) on provision 
of MA services to 
clients 
 
Decliners and Acceptors had  different 
reasons for their positions 
• Some of the reasons given by decliners:  
• “Abortion is illegal, morally wrong”  
• “Not trained any body in this service   
•  “We lack appropriate drugs” 
• ‘Due to personal beliefs: “Abortion kills” “It is a 
big sin”, “God is against killing” 
• Acceptors: 
 Should be legalized 
 “the study will help Govt. improve policies” 
  “Improves lives of women: Reduces Mmorb/mort  
   “Abortion also protects the interests of children”   
Interactions/Counseling dominated by Money 
 None mentioned health issues. They were concerned 
with money to be paid. BM RA-MBS 
 “I was given more information when I promised to 
raise half the amount. LO RA-KSM 
 Clients were assisted when they informed the 
provider of money they had. HM RA-NRB (QC) 
 Reluctant to use medical abortion methods. 
(Preference for surgical methods).  
 “Some providers would let us know that this was a 
business for making money apart from helping”. 
FMM RA-NRB (QC) 
 
Providers’ Attitude and Values (FP) 
 • Some PAs were judgmental and seem to suggest 
that  there wasn’t any need for FP since ‘the damage 
had been done already’. Examples:  
Tumalizane na abortion kwanza, FP haiwezi 
kukusaidia (Let us first of all finish with the 
business of Abortion, FP can not help you)LO 
(RA-KSM). 
 “You should have thought about it before you got 
yourself in such a mess,”. BM (RA-MBS) 
 “Couldn’t you think of using condoms, FP is not 
my concern” SB (RA-NRB) 
 “What method were you using? Did it backfire on 
you?”VA (RA-NRB) 
 
 
CONCLUSION & RECOMMENDATIONS 
• Abortion environment – changes since 2010. 
• Safe abortion services more available now   
• However, challenges/barriers still remain      
(stigma, inadequate HPs, commodities, 
   ignorance of the law & lack of pol/direction) 
• Preparedness of pharmacies to provide MA 
low 
• Overall sales of miso & mife were low 
• Very few clients (out of those who sought 
MA) received FP services 
RECOMMENDATIONS CONT’D 
• MOH to provide a clear policy statement on 
safe abortion services,  
• Dissemination of s/and guidelines for 
managing unsafe abortion/ training of HPs,  
• Awareness creation (community level and 
within the public sector) to reduce “fear”. 
• Need to make commodities for SA available 
• Increase the capacity of HPs in CAC services  
• Expand training of HPs in VCAT for MA & FP 
 
Thank You! 
 
 
& now time for 
 
Questions and Issues 
for clarification 
